Ntambwe Malangu is a pharmacopepidemiologist with public health expertise in drug utilization and safety. He is a Head of Department of Epidemiology and Biostatistics at the School of Public Health at Sefako Makgatho Health Sciences University. He teaches post-graduate students in the Post-graduate Diploma, Master and Doctor of Public Health programs. He has worked in both private and public sector of the healthcare industry in several African countries and from 2006, he has been working as a technical advisor to several Ministries of Health in Africa. He is a well-known trainer in supply chain management of health commodities and pharmaceuticals as well as in pharmacy practice and on topical issues relating to the pharmaceutical matters. Malangu holds a Bachelor degree in Pharmacy from the University of Kinshasa and a Master of Medical Science degree in Pharmacology from the Medical University of Southern Africa, a PhD (Pharmacology) and a Doctor of Medical Science (Injury Epidemiology) from the University of Limpopo. Malangu has published over 50 abstracts, full papers, and scientific letters pertaining to pharmacy practice, public health, toxicology, clinical practice, management, HIV/AIDS and tuberculosis. He has authored several book chapters and co-authored a clinical guidebook on the management of antiretroviral side effects (National Department of Health, 2004). He was an invited contributor to the “Leadership Journal” of the Gauteng Management Development Program. He is currently the Production Editor for PULA: Bostwana Journal for African studies. He is also a reviewer for several international peer-reviewed journals. A s recognition for his accomplishments in research, Malangu was the recipient of the Medunsa Senate Award for Beginner Researcher in the Faculty of Medicine in 2002. He was the first prize winner for “best oral presentation” during the Mpumalanga Pharmaceutical conference in 2000. In 2006, he was the recipient of the University of Limpopo’ Best Upcoming Researcher.
Ntambwe Malangu Research Interests are Health Sciences: public health pharmacy, pharmacoepidemiology, pharmacovigilance, tuberculosis, HIV/AIDS, drug safety issues and injury epidemiology.